Neuronal plasma membrane ganglioside-rich microdomain (GEM)

Neuronal plasma membrane ganglioside-rich microdomains, also known as ganglioside-enriched microdomains (GEMs) or lipid rafts, are specialized, highly ordered membrane regions enriched in cholesterol, sphingolipids, and gangliosides (Sonnino & Prinetti, 2010). These microdomains act as essential scaffolds for organizing signaling complexes, including neurotrophic factor receptors and ion channels, which are vital for synaptic plasticity and neuronal maintenance (Schengrund, 2010). In neurodegenerative conditions such as Alzheimer's and Parkinson's diseases, these microdomains facilitate the aggregation of pathogenic proteins like amyloid-beta and alpha-synuclein, promoting neurotoxicity (Fantini & Yahi, 2011). Pharmacological targeting of these domains involves modulating their lipid composition, primarily through substrate reduction therapies like Miglustat that inhibit ganglioside synthesis, or by using cholesterol-depleting agents to disrupt raft stability (Michel & Bakovic, 2007). However, therapeutic development is complicated by the need to preserve the integrity of physiological signaling pathways that depend on these microdomains for proper neuronal function. Furthermore, the presence of anti-ganglioside antibodies in certain autoimmune neuropathies highlights the delicate balance required when modulating these structures.

Other names

Lipid raftGanglioside-enriched microdomainDetergent-resistant membraneDRMSphingolipid-cholesterol raft

Substrate reduction therapy via inhibition of glucosylceramide synthase to reduce ganglioside levels; depletion of membrane cholesterol to disrupt microdomain assembly; modulation of raft-associated signaling complexes.